7.5800
23-April-25 10:43:09
15 minutes delayed
Stocks
+0.5700
+8.13%
Today's range
7.3750 - 7.8600
ISIN
N/A
Source
NASDAQ
Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio
23 Feb 2021 08:15:00 By Nasdaq GlobeNewswire
Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection
23 Feb 2021 06:30:00 By Nasdaq GlobeNewswire
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
02 Feb 2021 15:05:00 By Nasdaq GlobeNewswire
Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics
11 Jan 2021 15:01:00 By Nasdaq GlobeNewswire